Curated News
By: NewsRamp Editorial Staff
August 18, 2026
AHA Launches 2026 Health Tech Competition to Accelerate Cardiovascular Innovation
TLDR
- Win the American Heart Association's 2026 Health Tech Competition to scale your solution into global cardiovascular care markets.
- The competition requires market-ready solutions with clinical or pilot data, viable business models, and finalists pitch at Scientific Sessions 2026.
- This competition accelerates tech that improves heart and brain health, ensuring evidence-based care reaches patients in need.
- Five finalists will pitch live at Scientific Sessions 2026 in Chicago, with the winner announced on Nov 9.
Impact - Why it Matters
This competition matters because it directly addresses the critical gap between innovative health technologies and their availability to patients. By accelerating the adoption of evidence-based solutions, it has the potential to improve outcomes for millions affected by cardiovascular disease and stroke, which remain leading causes of death worldwide. For healthcare providers, it means access to validated tools that can enhance care delivery and efficiency. For innovators, it offers a pathway to scale and attract investment. Ultimately, patients stand to benefit from faster access to cutting-edge treatments and preventive measures, making this a significant step toward more equitable and effective healthcare.
Summary
The American Heart Association (AHA) has opened applications for its 2026 Health Tech Competition, a global initiative designed to bridge the gap between promising health technologies and their real-world implementation in cardiovascular and brain health care. Hosted by the AHA’s Center for Technology & Innovation, the competition seeks market-ready solutions backed by clinical or pilot data and a viable business model. Five finalists will be selected to pitch their innovations live at Scientific Sessions 2026, the AHA’s flagship event, scheduled for November 6–9 at McCormick Place in Chicago. The competition aims to accelerate the adoption of evidence-based technologies that can improve prevention, diagnosis, and treatment of conditions like high blood pressure, stroke, and heart failure.
Cardiovascular disease remains the leading cause of death globally, and health systems are grappling with workforce shortages and rising costs. The Health Tech Competition connects innovators with clinicians, researchers, and investors to fast-track the deployment of scalable, data-driven solutions. Nancy Brown, CEO of the American Heart Association, emphasized the organization’s century-long commitment to innovation, stating that the competition helps advance evidence-based solutions to pressing health challenges, reaching people where they live and receive care. Unlike typical startup contests, this program stresses clinical validation and alignment with evidence-based care, ensuring solutions are positioned for real-world adoption.
Key dates include applications open through September 18, 2026, finalists announced on October 10, live pitches on November 7–8, and the winner announced on November 9. The competition is a cornerstone of the Health Innovation Pavilion at Scientific Sessions. For more details, visit ahahealthtech.org/aha-health-tech-competition-2026. The AHA also highlighted the importance of artificial intelligence in healthcare, referencing a recent study, and encourages interested parties to follow @HeartNews on X for updates.
Source Statement
This curated news summary relied on content distributed by NewMediaWire. Read the original source here, AHA Launches 2026 Health Tech Competition to Accelerate Cardiovascular Innovation
